In last trading session, NeuroPace Inc (NASDAQ:NPCE) saw 0.87 million shares changing hands with its beta currently measuring 2.21. Company’s recent per share price level of $17.49 trading at $0.41 or 2.40% at ring of the bell on the day assigns it a market valuation of $573.65M. That closing price of NPCE’s stock is at a discount of -1.37% from its 52-week high price of $17.73 and is indicating a premium of 68.84% from its 52-week low price of $5.45. Taking a look at company’s average trading volume for last 10-days demonstrates a volume of 0.3 million shares which gives us an average trading volume of 227.15K if we extend that period to 3-months.
For NeuroPace Inc (NPCE), analysts’ consensus is at an average recommendation of Buy while assigning it a mean rating of 1.00. Splitting up the data highlights that, out of 5 analysts covering the stock, 1 rated the stock as a Sell while 0 recommended an Overweight rating for the stock. 2 suggested the stock as a Hold whereas 2 see the stock as a Buy. 0 analyst(s) advised it as an Underweight.
NeuroPace Inc (NASDAQ:NPCE) trade information
Upright in the green during last session for gaining 2.40%, in the last five days NPCE remained trading in the green while hitting it’s week-highest on Friday, 05/16/25 when the stock touched $17.49 price level, adding 2.02% to its value on the day. NeuroPace Inc’s shares saw a change of 56.30% in year-to-date performance and have moved 35.69% in past 5-day. NeuroPace Inc (NASDAQ:NPCE) showed a performance of 67.69% in past 30-days. Number of shares sold short was 0.39 million shares which calculate 2.38 days to cover the short interests.
Wall Street analysts have assigned a consensus price target of 13 to the stock, which implies a fall of -34.54% to its current value. Analysts have been projecting 5.5 as a low price target for the stock while placing it at a high target of 20. It follows that stock’s current price would jump 68.55% in reaching the projected high whereas dropping to the targeted low would mean a gain of 68.55% for stock’s current value.
Weighing up company’s earnings over the past 5-year and in the next 5-year periods, we find the company posting an annual earnings growth rate of 5.83% during past 5 years. In 2025, company’s earnings growth rate is likely to be around 11.20% while estimates for its earnings growth in next 5 years are of 29.55%.
NeuroPace Inc (NASDAQ:NPCE)’s Major holders
Insiders are in possession of 16.12% of company’s total shares while institution are holding 84.87 percent of that, with stock having share float percentage of 101.18%. Investors also watch the number of corporate investors in a company very closely, which is 84.87% institutions for NeuroPace Inc that are currently holding shares of the company. ORBIMED ADVISORS LLC is the top institutional holder at NPCE for having 3.41 million shares of worth $25.75 million. And as of 2024-06-30, it was holding 12.0428 of the company’s outstanding shares.
The second largest institutional holder is MORGAN STANLEY, which was holding about 2.47 million shares on 2024-06-30. The number of shares represents firm’s hold over 8.7365 of outstanding shares, having a total worth of $18.68 million.
On the other hand, VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund and iShares Trust-iShares Russell 2000 ETF are the top two Mutual Funds which own company’s shares. As of Dec 31, 2024 , the former fund manager was holding 700.52 shares of worth $12.25 million or 2.14% of the total outstanding shares. The later fund manager was in possession of 376.95 shares on Mar 31, 2025 , making its stake of worth around $6.59 million in the company or a holder of 1.15% of company’s stock.
